Cationic nanoemulsions as potential carriers for intracellular delivery

Saudi Pharmaceutical Journal

Volumn 23, Issue 2, 2015, Pages 188-194

  Khachane, P V ^a   Jain, A S ^a   Dhawan, V V ^a   Joshi, G V ^b   Date, A A ^a,c   Mulherkar, R ^b   Nagarsenker, M S ^a  

^a BOMBAY COLLEGE OF PHARMACY   (India)

^b CANCER RESEARCH INSTITUTE   (India)

^c CREIGHTON UNIVERSITY SCHOOL OF PHARMACY AND HEALTH PROFESSIONS   (United States)

Author keywords

Cationic; Cytosolic delivery; Didodecyldimethylammonium bromide; Intracellular delivery; Nanoemulsion

Indexed keywords

DIDODECYLDIMETHYLAMMONIUM BROMIDE; DNA; DRUG CARRIER; GLYCEROL; OCTANOIN; PHOSPHOLIPID; POLOXAMER; STABILIZING AGENT;

ARTICLE; CONCENTRATION (PARAMETERS); DRUG DELIVERY SYSTEM; EMBRYO; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; IN VIVO STUDY; KIDNEY CELL; NANOEMULSION; NANOFABRICATION; PARTICLE SIZE;

EID: 84938961320     PISSN: 13190164     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsps.2014.07.007     Document Type: Article

References (16)

1. Belting M. Heparan sulfate proteoglycan as a plasma membrane carrier. Trends Biochem. Sci. 2003, 28:145-151.
2. Campbell R.B., Fukumura D., Brown E.B., et al. Cationic charge determines the distribution of liposomes between the vascular and extravascular compartments of tumors. Cancer Res. 2002, 62:6831.
3. Chou L.Y., Ming K., Chan W.C. Strategies for the intracellular delivery of nanoparticles. Chem. Soc. Rev. 2011, 40:233-245.
4. de Araújo S.C., de Mattos A.C.A., Teixeira H.F., et al. Improvement of in vitro efficacy of a novel schistosomicidal drug by incorporation into nanoemulsions. Int. J. Pharm. 2007, 337:307-315.
5. Hung C.F., Hwang T.L., Chang C.C., et al. Physicochemical characterization and gene transfection efficiency of lipid emulsions with various co-emulsifiers. Int. J. Pharm. 2005, 289:197-208.
6. Jain A.S., Khachane P.V., Shah S.M., et al. Nanoemulsions: a potential delivery system. The Pharma Review 2011, 113-119.
7. Jayakumar R., Chennazhi K., Muzzarelli R., et al. Chitosan conjugated DNA nanoparticles in gene therapy. Carbohydr. Polym. 2010, 79:1-8.
8. Liu C.H., Yu S.Y. Cationic nanoemulsions as non-viral vectors for plasmid DNA delivery. Colloids Surf., B 2010, 79:509-515.
9. Mansouri S., Lavigne P., Corsi K., et al. Chitosan-DNA nanoparticles as non-viral vectors in gene therapy: strategies to improve transfection efficacy. Eur. J. Pharm. Biopharm. 2004, 57:1-8.
10. Mislick K.A., Baldeschwieler J.D. Evidence for the role of proteoglycans in cation-mediated gene transfer. Proc. Natl. Acad. Sci. U.S.A. 1996, 93:12349.
11. Mounkes L.C., Zhong W., Cipres-Palacin G., et al. Proteoglycans mediate cationic liposome-DNA complex-based gene delivery in vitro and in vivo. J. Biol. Chem. 1998, 273:26164.
12. Quong D., Neufeld R. DNA protection from extracapsular nucleases, within chitosan-or poly-L-lysine-coated alginate beads. Biotechnol. Bioeng. 1998, 60:124-134.
13. Shah L.K., Amiji M.M. Intracellular delivery of saquinavir in biodegradable polymeric nanoparticles for HIV/AIDS. Pharm. Res. 2006, 23:2638-2645.
14. Smith J., Zhang Y., Niven R. Toward development of a non-viral gene therapeutic. Adv. Drug Deliv. Rev. 1997, 26:135-150.
15. Torchilin V.P. Recent approaches to intracellular delivery of drugs and DNA and organelle targeting. Annu. Rev. Biomed. Eng. 2006, 8:343-375.
16. Xiong X.B., Huang Y., Lu Wl., et al. Enhanced intracellular delivery and improved antitumor efficacy of doxorubicin by sterically stabilized liposomes modified with a synthetic RGD mimetic. J. Controlled Release 2005, 107:262-275.